NCT01008605View on ClinicalTrials.gov

Caverject User Study

PHASE3CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Erectile Dysfunction
Interventions
OTHER

delivery system

syringe

Trial Locations (2)

66211

Pfizer Investigational Site, Overland Park

66212

Pfizer Investigational Site, Overland Park

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01008605 - Caverject User Study | Biotech Hunter | Biotech Hunter